NCT03000413View on ClinicalTrials.gov

Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 4, 2015

Primary Completion Date

June 16, 2017

Study Completion Date

January 29, 2018

Conditions
Critical IllnessAsthmaBronchospasm
Interventions
DRUG

Ketamine

Active treatment

DRUG

Fentanyl

Trial Locations (1)

Unknown

Hospital Nossa Senhora da Conceição, Porto Alegre

All Listed Sponsors
lead

Hospital Nossa Senhora da Conceicao

OTHER

NCT03000413 - Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial | Biotech Hunter | Biotech Hunter